ストックスクリーナーアプリを入手
2.00
2.44%
-0.05
前日終値:
$2.05
開ける：
$2.02
24時間の取引高:
639.79K
Relative Volume:
0.47
時価総額：
$276.55M
収益：
-
当期純損益:
$-101.70M
株価収益率:
-1.0548
EPS:
-1.8961
ネットキャッシュフロー:
$-84.35M
1週間 パフォーマンス:
-1.96%
1か月 パフォーマンス:
+0.50%
6か月 パフォーマンス:
-5.21%
1年 パフォーマンス:
+75.44%
1日の値動き範囲:
$1.98
$2.04
1週間の範囲:
$1.95
$2.055
52週間の値動き範囲:
$0.96
$2.66
Alx Oncology Holdings Inc Stock (ALXO) Company Profile
名前
Alx Oncology Holdings Inc
セクター
電話
650-466-7125
住所
323 ALLERTON AVENUE, SOUTH SAN FRANCISCO
Compare ALXO vs VRTX, REGN, ARGX, MRNA, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ALXO
Alx Oncology Holdings Inc
|
2.00 | 275.17M | 0 | -101.70M | -84.35M | -1.8961 |
VRTX
Vertex Pharmaceuticals Inc
|
541.69 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
794.19 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,023.21 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
137.99 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
207.88 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Alx Oncology Holdings Inc Stock (ALXO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-19 | 開始されました | Wells Fargo | Overweight |
| 2026-03-06 | 再開されました | UBS | Buy |
| 2025-11-13 | 開始されました | Jefferies | Buy |
| 2025-03-06 | アップグレード | Jefferies | Hold → Buy |
| 2024-12-19 | ダウングレード | Jefferies | Buy → Hold |
| 2024-03-08 | ダウングレード | Stifel | Buy → Hold |
| 2023-12-08 | アップグレード | Jefferies | Hold → Buy |
| 2021-12-22 | ダウングレード | Jefferies | Buy → Hold |
| 2021-09-30 | 開始されました | Stifel | Buy |
| 2021-05-05 | 再開されました | Credit Suisse | Outperform |
| 2021-04-26 | 再開されました | Credit Suisse | Outperform |
| 2021-04-06 | 開始されました | UBS | Buy |
| 2021-02-10 | 開始されました | H.C. Wainwright | Buy |
| 2020-08-11 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-08-11 | 開始されました | Credit Suisse | Outperform |
| 2020-08-11 | 開始されました | Jefferies | Buy |
| 2020-08-11 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Alx Oncology Holdings Inc (ALXO) 最新ニュース
ALX (ALXO) EPS and Revenue: EPS Beats Its Estimate in the Latest Session; Stock Move: Shares Close 0.96% Lower on the DayEarnings Preview - vinanet.vn
HC Wainwright Has Positive View of ALX Oncology Q3 Earnings - MarketBeat
ALX Oncology Holdings Inc (ALXO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Alx oncology CEO Jason Lettmann disposes of $4,303 in shares - Investing.com
Alx oncology CEO Jason Lettmann disposes of $4,303 in shares By Investing.com - Investing.com India
Alx Oncology SVP Shelly Wong sells $1,105 of company stock - Investing.com
ALX Oncology (NASDAQ: ALXO) CEO trims stake for taxes - Stock Titan
Piper Sandler Maintains ALX Oncology(ALXO.US) With Buy Rating, Maintains Target Price $4 - Moomoo
ALX Oncology (ALXO) SVP Finance sells shares for taxes - Stock Titan
ALXO Q2 2026 Earnings: Narrower-Than-Expected Loss Delivers 17.9% EPS SurpriseEPS Consistency Score - Vinanet
ALX Oncology (ALXO) Holds Near $1.96 as Biotech Stock Consolidates Below ResistanceSingle Stock ETF - dars.gov.et
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
TCG Crossover group (NASDAQ: ALXO) reports 4.2% ALX Oncology stake in 13G/A - Stock Titan
ALXO Q2 2026 Earnings: EPS Beat of 17.92% Lifts Shares 4.15%Downward Estimate Revision - Vinanet
Is ALX Oncology Holdings (ALXO) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
H.C. Wainwright Maintains ALX Oncology(ALXO.US) With Buy Rating, Maintains Target Price $4 - Moomoo
ALX Oncology Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView
ALX Oncology Holdings Inc expected to post a loss of 15 cents a shareEarnings Preview - TradingView
ALX Oncology (ALXO) Holds Steady at $2.10 as Shares Consolidate Near Key SupportSell Signal Alerts - vinanet.vn
ALX Oncology (NASDAQ:ALXO) Issues Earnings Results - MarketBeat
ALX Oncology Holdings Inc 2Q 2026: Net loss $17.97M, Diluted EPS $(0.13) — 10-Q Summary - TradingView
ALXO: Q2 2026 net loss narrowed, expenses fell, and cash reserves support operations into 2028 - TradingView
Is ALX Oncology Holdings Inc (ALXO) Turning a Corner After Q2 Ea - GuruFocus
ALX Oncology Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
ALX Oncology Reports Second Quarter 2026 Financial Results and Provides Corporate Update - Investing News Network
ALX Oncology Reports Q2 2026 Net Loss of $18 Million - Quiver Quantitative
ALX Oncology reports Q2 2026 net loss of $18.0M, $153.4M cash; advances evorpacept and ALX2004 - TradingView
ALXO: Reduced net loss, robust cash position, and advancing clinical milestones drive outlook - TradingView
Clinical pipeline accelerates as ALX Oncology posts Q2 results and updates on ALX2004 study - Traders Union
ALXO Q2'26 Earnings: EPS estimate is (0.14) USD - TradingView
ALX Oncology (ALXO) Projected to Post Earnings on Tuesday - MarketBeat
ALX Oncology Holdings (ALXO) Holds Steady Near $1.94 as Biotech Sector Watches Key LevelsUnusual Call Volume - dars.gov.et
ALX Oncology (ALXO) Holds Near $1.94 as Shares Dip 0.51%Technical Analysis - vinanet.vn
Vivo Capital LLC Buys Shares of 3,184,713 ALX Oncology Holdings Inc. $ALXO - MarketBeat
ALXO Q2'26 Earnings: revenue estimate is 0 USD - TradingView
Redmile Group LLC Acquires 4,699,470 Shares of ALX Oncology Holdings Inc. $ALXO - MarketBeat
ALX Oncology Holdings Inc (ALXO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
ALX Oncology Holdings Inc. $ALXO Stock Position Boosted by venBio Partners LLC - MarketBeat
BlackRock (NYSE: BLK) reports 5.4% passive stake in ALX Oncology (ALXO) - Stock Titan
ALX Oncology Holdings Inc (ALXO) Cash Flow - TradingKey
2,866,256 Shares in ALX Oncology Holdings Inc. $ALXO Purchased by Orbimed Advisors LLC - MarketBeat
ALX Oncology Holdings Inc (ALXO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
ALXO|ALX Oncology Holdings Inc|Price:2.030|Chg%:+0.010 - TradingKey
ALX Oncology Holdings Inc (ALXO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
ALXO|ALX Oncology Holdings Inc|Price:2.020|Chg%:-0.010 - TradingKey
TradingKey - TradingKey
ALX Oncology Holdings Inc. Revenue Breakdown – NASDAQ:ALXO - TradingView
ALX Oncology Holdings Inc (ALXO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Alx Oncology Holdings, Inc. (ALXO) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
Alx Oncology Holdings, Inc. (ALXO) Q2 2025 Earnings ReportResults, Call & Slides - TipRanks
Alx Oncology Holdings, Inc. (ALXO) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
Alx Oncology Holdings Inc (ALXO) 財務データ
収益
当期純利益
現金流量
EPS
Alx Oncology Holdings Inc (ALXO) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Wong Shelly | SVP, FINANCE AND CAO |
Aug 17 '26 |
Sale |
1.93 |
573 |
1,106 |
87,828 |
| Wong Shelly | SVP, FINANCE AND CAO |
Jul 01 '26 |
Sale |
2.04 |
1,404 |
2,864 |
88,401 |
| Lettmann Jason | CHIEF EXECUTIVE OFFICER |
Mar 19 '26 |
Sale |
2.17 |
12,311 |
26,715 |
293,609 |
| Pinto Shelly | SVP, FINANCE AND CAO |
Mar 19 '26 |
Sale |
2.17 |
903 |
1,960 |
86,805 |
| Pinto Shelly | SVP, FINANCE AND CAO |
Feb 18 '26 |
Sale |
2.27 |
565 |
1,283 |
87,708 |
| GOODMAN COREY S | Director |
Feb 02 '26 |
Buy |
1.57 |
3,184,713 |
4,999,999 |
8,453,038 |
| Pinto Shelly | SVP, FINANCE AND CAO |
Jan 06 '26 |
Sale |
1.11 |
3,925 |
4,357 |
88,273 |
| Lettmann Jason | CHIEF EXECUTIVE OFFICER |
Sep 17 '25 |
Buy |
1.08 |
71,163 |
76,892 |
305,121 |
| Lettmann Jason | CHIEF EXECUTIVE OFFICER |
Sep 16 '25 |
Buy |
1.07 |
21,070 |
22,461 |
233,958 |
8.37%
0.23%
大文字化:
|
ボリューム (24 時間):